“I would not be able to do this work without the support of common resources accumulated at MICHR. I value the work I am able to do at U-M and so much of it is enabled by the MICHR team. They are fundamental to getting good clinical research done at Michigan.”

The MICHR Expanded Access program is a fantastic resource. The Expanded Acccess process is pretty complicated, requiring communications with the FDA, the University institutional review board, the pharmaceutical company, and lots of documentation. Early in the COVID-19 epidemic, I worked with the TEAMSS staff to obtain remdesivir for some of our first patients at Michigan Medicine. All I had to do was decide on the drug and they pretty much took care of the rest. They were available after hours and on weekends. They ‘made it happen.’

I was finding research funding options to be very complicated and confusing, until I stumbled upon the MICHR webpage… cue ray of light and angels singing. The resources on this page were exactly what I had been searching for.

These types of resources have been enormously helpful for this project. This project wouldn’t be possible without MICHR. 

That’s been really helpful, having outside observers really read through the grant and critique it. Sometimes on the departmental level it’s hard to get people to really read through a grant proposal thoroughly and the RDC is pretty great for that.

I think your service is wonderful and I will be recommending it highly to my SPH colleagues. 

This experience with MICHR is the best example of the 'Michigan Difference' and I can't thank you enough for all you do.

I am constantly amazed at the wealth of resources at U-M. Your efforts (at) MICHR are a prime example of how opportunities are created here.

I was stuck, and you helped me get unstuck.

MICHR is an exceptional resource for UMHS research teams. As a clinical investigator, I've wondered whether I'm benefitting from the indirect costs charged to our grants. After working with MICHR, I know the answer is yes.

Assistance from MICHR was invaluable in negotiating the complex regulatory framework to create life-saving devices for children. Getting these devices to children would have taken years longer, if even possible, without stepwise guidance and early translational support from MICHR. MICHR's support has literally saved several children that would have otherwise passed away.